PDAC
Clinical trials for PDAC explained in plain language.
Never miss a new study
Get alerted when new PDAC trials appear
Sign up with your email to follow new studies for PDAC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug targets Hard-to-Treat cancers with RAS mutations
Disease control Not yet recruitingThis study tests a new drug called GFH276 in people with advanced cancers that have a specific genetic change called a RAS mutation. The cancers include pancreatic, lung, and colorectal cancer. The goal is to find a safe dose and see if the drug can shrink tumors. About 450 adult…
Matched conditions: PDAC
Phase: PHASE1, PHASE2 • Sponsor: Genfleet Therapeutics (Shanghai) Inc. • Aim: Disease control
Last updated Jun 16, 2026 12:48 UTC
-
Massive GI cancer registry launches to unlock secrets of the disease
Knowledge-focused Not yet recruitingThis study is creating a large database of medical information and biological samples from up to 100,000 people with gastrointestinal cancers, including pancreatic and colorectal cancer. The goal is to track patient experiences over time, identify best practices, and support futu…
Matched conditions: PDAC
Sponsor: Canopy Cancer Collective, LLC • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:05 UTC